Overview

IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to better understand the factors present in the cells of inflamed joints of patients with arthritis that may cause rheumatoid arthritis. Knowledge gained from this study may lead to new and better therapies for arthritis.
Phase:
Phase 4
Details
Lead Sponsor:
University of Illinois at Chicago
Collaborator:
UCB Pharma
Treatments:
Certolizumab Pegol
Hydroxychloroquine
Leflunomide
Methotrexate
Naproxen
Prednisone
Sulfasalazine
Triamcinolone